Korean Post-marketing Surveillance for Xeljanz XR

Clinical trial NCT04876781 · RECRUITING

Trial details

NCT number: NCT04876781
Sponsor: Pfizer
Status: RECRUITING
Study type: OBSERVATIONAL

Active Moderate to Severe Rheumatoid Arthritis Active Ankylosing Spondylitis Active Psoriatic Arthritis

Start date: 2022-01-12
Primary completion: 2026-09-22
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.